Skip to content
Their Record

Senate Roll Call 344, 112th Congress · May 24, 2012

To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws.

Question before the chamber: On the Amendment

9 yea · 88 nayAmendment Rejected3 not voting or present
Democrat7 yea · 42 nay
Republican1 yea · 44 nay
Independent1 yea · 2 nay

Solid = yea, faded = nay.

The measure

S. 3187

Food and Drug Administration Safety and Innovation Act

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

  • Health CareA yea counts toward “Expand coverage”

    model(0.80): Revoking drug exclusivity encourages generic competition and expands affordable healthcare access.

    Tagged by: policy-area:Health

    Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.